Mawer Investment Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-339,387
| Closed | -$21.4M | – | 97 |
|
|
2020
Q3 | $21.4M | Sell |
339,387
-352,940
| -51% | -$22.3M | 0.14% | 76 |
|
|
2020
Q2 | $53.3M | Sell |
692,327
-277,655
| -29% | -$21.4M | 0.39% | 51 |
|
|
2020
Q1 | $72.5M | Buy |
969,982
+9,805
| +1% | +$733K | 0.67% | 39 |
|
|
2019
Q4 | $62.4M | Buy |
960,177
+37,524
| +4% | +$2.44M | 0.51% | 44 |
|
|
2019
Q3 | $58.5M | Buy |
922,653
+18,500
| +2% | +$1.17M | 0.53% | 43 |
|
|
2019
Q2 | $61.1M | Buy |
904,153
+73,290
| +9% | +$4.95M | 0.4% | 62 |
|
|
2019
Q1 | $54M | Sell |
830,863
-690
| -0.1% | -$44.9K | 0.38% | 60 |
|
|
2018
Q4 | $52M | Buy |
831,553
+3,380
| +0.4% | +$211K | 0.43% | 60 |
|
|
2018
Q3 | $63.9M | Buy |
828,173
+60,206
| +8% | +$4.65M | 0.48% | 57 |
|
|
2018
Q2 | $54.4M | Buy |
767,967
+47,970
| +7% | +$3.4M | 0.44% | 60 |
|
|
2018
Q1 | $54.3M | Buy |
719,997
+39,517
| +6% | +$2.98M | 0.45% | 59 |
|
|
2017
Q4 | $48.8M | Buy |
680,480
+102,310
| +18% | +$7.33M | 0.4% | 60 |
|
|
2017
Q3 | $46.8M | Buy |
578,170
+12,600
| +2% | +$1.02M | 0.4% | 63 |
|
|
2017
Q2 | $40M | Sell |
565,570
-530
| -0.1% | -$37.5K | 0.37% | 65 |
|
|
2017
Q1 | $38.5M | Buy |
566,100
+84,040
| +17% | +$5.71M | 0.37% | 67 |
|
|
2016
Q4 | $34.5M | Buy |
482,060
+191,970
| +66% | +$13.7M | 0.35% | 67 |
|
|
2016
Q3 | $23M | Buy |
+290,090
| New | +$23M | 0.24% | 70 |
|